{"filing":{"accession":"0001159036-26-000108","url":"/filing/0001159036-26-000108","form_type":"4","issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_name_source":null,"issuer_ticker":"HALO","issuer_url":"/issuer/0001159036","period_of_report":"2026-08-17","filed_date":"2026-08-19","acceptance_dt":"2026-08-19T20:01:15+00:00","acceptance_label":"2026-08-19 20:01 UTC","ingested_at":"2026-08-20T05:22:56.381658+00:00","ingested_label":"2026-08-20 05:22 UTC","schema_version":null,"source":"Layline","parse_status":"parsed","parse_ok":true,"edgar_url":"https://www.sec.gov/Archives/edgar/data/1159036/0001159036-26-000108-index.htm","day_url":"/filings/2026-08-19"},"owners":[{"owner_cik":"0001528185","owner_name":"Torley Helen","url":"/insider/0001528185","anchor":"owner-0001528185","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","is_director":true,"is_officer":true,"is_ten_percent":false,"is_other":false,"filing_anchor":"/filing/0001159036-26-000108#owner-0001528185"}],"line_owners":[{"owner_name":"Torley Helen","role":"Director, Officer (PRESIDENT AND CEO)"}],"transactions":[{"id":9298603,"accession":"0001159036-26-000108","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001159036-26-000108","line_url":"/filing/0001159036-26-000108#line-1","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_display_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":98.958,"price_display":"98.96","price_state":"stated","total_value":89062.2,"total_display":"89,062.20","total_whole":"89,062","shares_owned_after":786880.0,"shares_owned_after_display":"786,880","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-17","filed_date":"2026-08-19","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9298604,"accession":"0001159036-26-000108","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001159036-26-000108","line_url":"/filing/0001159036-26-000108#line-2","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_display_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":100.457,"price_display":"100.46","price_state":"stated","total_value":50228.5,"total_display":"50,228.50","total_whole":"50,229","shares_owned_after":786380.0,"shares_owned_after_display":"786,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-17","filed_date":"2026-08-19","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9298605,"accession":"0001159036-26-000108","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001159036-26-000108","line_url":"/filing/0001159036-26-000108#line-3","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_display_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2100.0,"shares_display":"2,100","price_per_share":101.766,"price_display":"101.77","price_state":"stated","total_value":213708.6,"total_display":"213,708.60","total_whole":"213,709","shares_owned_after":784280.0,"shares_owned_after_display":"784,280","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-17","filed_date":"2026-08-19","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9298606,"accession":"0001159036-26-000108","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001159036-26-000108","line_url":"/filing/0001159036-26-000108#line-4","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_display_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":102.553,"price_display":"102.55","price_state":"stated","total_value":922977.0,"total_display":"922,977.00","total_whole":"922,977","shares_owned_after":775280.0,"shares_owned_after_display":"775,280","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-17","filed_date":"2026-08-19","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9298607,"accession":"0001159036-26-000108","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001159036-26-000108","line_url":"/filing/0001159036-26-000108#line-5","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_display_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":103.482,"price_display":"103.48","price_state":"stated","total_value":776115.0,"total_display":"776,115.00","total_whole":"776,115","shares_owned_after":767780.0,"shares_owned_after_display":"767,780","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-17","filed_date":"2026-08-19","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9298608,"accession":"0001159036-26-000108","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001159036-26-000108","line_url":"/filing/0001159036-26-000108#line-6","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_display_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5703.0,"shares_display":"5,703","price_per_share":103.083,"price_display":"103.08","price_state":"stated","total_value":587882.349,"total_display":"587,882.35","total_whole":"587,882","shares_owned_after":782077.0,"shares_owned_after_display":"782,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-18","filed_date":"2026-08-19","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9298609,"accession":"0001159036-26-000108","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001159036-26-000108","line_url":"/filing/0001159036-26-000108#line-7","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_display_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4897.0,"shares_display":"4,897","price_per_share":104.11,"price_display":"104.11","price_state":"stated","total_value":509826.67,"total_display":"509,826.67","total_whole":"509,827","shares_owned_after":777180.0,"shares_owned_after_display":"777,180","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-18","filed_date":"2026-08-19","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9298610,"accession":"0001159036-26-000108","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001159036-26-000108","line_url":"/filing/0001159036-26-000108#line-8","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_display_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9400.0,"shares_display":"9,400","price_per_share":104.874,"price_display":"104.87","price_state":"stated","total_value":985815.6,"total_display":"985,815.60","total_whole":"985,816","shares_owned_after":767780.0,"shares_owned_after_display":"767,780","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-18","filed_date":"2026-08-19","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9298611,"accession":"0001159036-26-000108","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001159036-26-000108","line_url":"/filing/0001159036-26-000108#line-9","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_display_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7200.0,"shares_display":"7,200","price_per_share":106.358,"price_display":"106.36","price_state":"stated","total_value":765777.6,"total_display":"765,777.60","total_whole":"765,778","shares_owned_after":780580.0,"shares_owned_after_display":"780,580","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-19","filed_date":"2026-08-19","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9298612,"accession":"0001159036-26-000108","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001159036-26-000108","line_url":"/filing/0001159036-26-000108#line-10","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_display_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9600.0,"shares_display":"9,600","price_per_share":107.224,"price_display":"107.22","price_state":"stated","total_value":1029350.4,"total_display":"1,029,350.40","total_whole":"1,029,350","shares_owned_after":770980.0,"shares_owned_after_display":"770,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-19","filed_date":"2026-08-19","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9298613,"accession":"0001159036-26-000108","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001159036-26-000108","line_url":"/filing/0001159036-26-000108#line-11","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001528185","owner_name":"Torley Helen","owner_display_name":"Torley Helen","owner_url":"/insider/0001528185","role":"Director, Officer (PRESIDENT AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3200.0,"shares_display":"3,200","price_per_share":107.765,"price_display":"107.76","price_state":"stated","total_value":344848.0,"total_display":"344,848.00","total_whole":"344,848","shares_owned_after":767780.0,"shares_owned_after_display":"767,780","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-19","filed_date":"2026-08-19","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null}],"n_transactions":11,"line_constants":{"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true},"provenance":{"source_pass":"Layline","parse_status":"parsed","schema_version":null,"retrieved_at":"2026-08-20T05:22:56.381658+00:00","retrieved_label":"2026-08-20 05:22 UTC","primary_document":"https://www.sec.gov/Archives/edgar/data/1159036/0001159036-26-000108-index.htm","accepted_at":"2026-08-19T20:01:15+00:00","accepted_label":"2026-08-19 20:01 UTC"},"related":[],"related_rule":"Other filings held for the same issuer and the same period of report. This is a heuristic match, not an authoritative amendment link: the store holds no 4/A-to-original relation and the catalog does not invent one.","canonical_url":"https://ebomi.com/filing/0001159036-26-000108","retrieved_at":"2026-08-25T01:11:49+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}